hydromorphone has been researched along with Pain in 221 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (10.41) | 18.7374 |
| 1990's | 35 (15.84) | 18.2507 |
| 2000's | 78 (35.29) | 29.6817 |
| 2010's | 65 (29.41) | 24.3611 |
| 2020's | 20 (9.05) | 2.80 |
| Authors | Studies |
|---|---|
| Barletta, M; Chang, K; Ishikawa, Y; Knych, H; Quandt, J; Reed, R; Sakai, D; Skrzypczak, H; Trenholme, N | 1 |
| Aydemir, B; Hakmeh, W; Hoyle, C | 1 |
| Gao, L; Wang, C; Wu, Z; Xu, H; Yao, Y; Zheng, F; Zhou, J | 1 |
| Bateman, BT; Esposito, DB; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Straub, L; Werler, MM | 1 |
| Miksys, S; Novalen, M; Richards, J; Tyndale, RF | 1 |
| Gong, X; Xie, S; Zhang, G; Zhang, Y | 1 |
| Escher, M; Hentsch, L; Singovski, S; Xausa, G | 1 |
| Chhunchha, P; Russo, K | 1 |
| Caputo, A; Christopher, C; Compton, P; Delgado, MK; Lowenstein, M; McFadden, R; Olenik, JM; Perrone, J; Ronning, K; Sigueza, AL; Thakrar, AP; Uritsky, TJ; Winston, A | 1 |
| Blood, J; Dahan, A; Göpfert, C; Kharasch, ED; Meissner, K; Olofsen, E; Wieditz, J | 1 |
| Coleska, A; Dinh, D; Oh, A; Parwani, V; Rothenberg, C; Venkatesh, AK | 1 |
| Ali, KA; Deng, X; Fang, Z; Li, W; Li, Y | 1 |
| Bakker, M; Kleinig, P; Patel, C; Tait, P | 1 |
| Chua, D; Jackson, LD; Selby, D; Wortzman, R | 1 |
| Dember, LM; Jhamb, M; Liebschutz, J; Roy, PJ; Weltman, M | 1 |
| D Trottier, E; Gélinas, C; Kleiber, N; Spénard, S; Tremblay-Racine, F | 1 |
| Borbasi, J; Krasovitsky, M | 1 |
| Bergeria, CL; Campbell, CM; Dunn, KE; Huhn, AS; Mun, CJ; Speed, TJ; Vandrey, R | 1 |
| Cai, Z; Chen, Y; Feng, S; Fu, J; Hong, L; Huang, C; Lai, T; Li, H; Li, X; Lin, G; Lin, R; Lin, S; Lin, Y; Lv, X; Wang, F; Wang, J; Wu, Q; Xin, M; Yang, S; Yao, Y; Zhang, G; Zhao, S; Zhu, J | 1 |
| Labonté, LE; Young, S | 1 |
| de Rooij, SE; Spies, PE; Swart, LM; van der Zanden, V; van Munster, BC | 1 |
| Bowen, JF; Pontiggia, L; Radcliff, JA; Rafeq, RM; Sen, S | 1 |
| Cua, A; Kilbourn, K; Krock, K; Lipnick, P; Pesce, A; Ritz, D; Rogers, R; Thomas, R | 1 |
| He, GZ; Xu, XM; Yang, C | 1 |
| Chessman, AW | 1 |
| Behm, B; Davis, MP; Fernandez, C; McPherson, ML; Mehta, Z | 1 |
| Evenson, EA; Mans, C | 1 |
| Foxwell, AM; Uritsky, TJ | 1 |
| DeGrado, JR; Dube, KM; Kovacevic, MP; Szumita, PM | 1 |
| Marra, EM; Mazer-Amirshahi, M; Mullins, P; Pines, JM | 1 |
| Bohnert, ASB; Cunningham, R; Dora-Laskey, A; Goldstick, J; Thomas, L; Walton, M; Whiteside, LK | 1 |
| Bruera, E | 1 |
| Beaufrère, H; Guzman, DS; Houck, EL; Knych, HK; Paul-Murphy, JR | 1 |
| Idzik, SK; McKinnon, M; Sohn, M; Storr, CL; Trinkoff, AM; Yang, BK | 1 |
| Berterame, S; Bosetti, C; Corli, O; Erthal, J; Radrezza, S; Santucci, C | 1 |
| Bigelow, GE; Edwards, RR; Huhn, AS; Smith, MT; Strain, EC; Tompkins, DA | 1 |
| Pang, H; Ren, R; Wang, D; Wang, H; Wang, X; Weber, L; Wei, X; Yang, J; Yuan, H; Zhao, G | 1 |
| Baetge, CL; Coursey, CD; Lizarraga, I; Scallan, EM; Simon, BT | 1 |
| Drazenovich, TL; Guzman, DS; Olsen, GH; Paul-Murphy, JR; Willits, NH | 1 |
| Navani, DM; Yoburn, BC | 1 |
| Quigley, C | 2 |
| Gregory, TB | 1 |
| Atayee, RS; Best, BM; Ma, JD; Yee, DA | 1 |
| Bruera, E; Hui, D; Kwon, JH; Reddy, A; Tanco, K | 1 |
| Bruera, E; Didwaniya, N; Gottumukkala, RS; Reddy, A | 1 |
| Mazer-Amirshahi, M; Mullins, PM; Pines, JM; Rasooly, I; van den Anker, J | 1 |
| Han, J; Hou, Y; Richards, HM; Shen, W; Yu, L; Yu, S | 1 |
| Christe, KL; Kelly, KR; Pypendop, BH | 1 |
| Cheung, W; Deyell, R; Görges, M; Lauder, G; West, N; Winton, P | 1 |
| Shelton, CP; Webb, RJ | 1 |
| Csikós, Á; Kullmann, T; Pintér, T; Sipőcz, I | 1 |
| Birnbaum, A; Chew, E; Choe, D; Hernandez, L; Xia, S | 1 |
| Clattenburg, E; Hahn, C; Herring, A; Johnson, B; Nagdev, A | 1 |
| Ensom, MH; MacKenzie, M; Zed, PJ | 1 |
| Bao, YJ; Hou, W; Hua, BJ; Knaggs, R; Kong, XY; Xia, J; Yang, L | 1 |
| Brudney, CS; Ehieli, E; Pyati, S; Yalamuri, S | 1 |
| Bond, BS | 1 |
| Turris, M | 1 |
| Greenfield, S; Jamison, RN; Janfaza, D; Michna, E; Teter, CJ; Wasan, AD | 1 |
| Rang, S; Rogers, BA | 1 |
| Bijur, PE; Campbell, CM; Chang, AK; Gallagher, EJ; Murphy, MK | 1 |
| Telekes, A | 1 |
| Baccelieri, A; Bijur, PE; Chang, AK; Gallagher, EJ | 1 |
| Anderson, BJ; Craig, F; Michel, E; Zernikow, B | 1 |
| Bijur, PE; Chang, AK; Davitt, M; Gallagher, EJ | 1 |
| Clinch, T; Dreitlein, D; Lacouture, PG; Rudy, AC; Suner, S; Wermeling, DP | 1 |
| O'Connor, AB | 1 |
| Bertholf, RL; Chronister, CW; Goldberger, BA; Reisfield, GM | 1 |
| Broussard, LA | 1 |
| Gourlay, D; Heit, HA | 1 |
| Ambros, B; Duke-Novakovski, T; Gilbert, P; Mantovani, F; Steagall, PV | 1 |
| Gröning, R; Richarz, U; Sathyan, G; Thipphawong, J; Turgeon, J | 1 |
| Alon, E; Cachin, C | 1 |
| Carter, NJ; Keating, GM | 1 |
| Finco, G; Lussier, D; Richarz, U | 1 |
| Goforth, HW | 1 |
| Eipe, N; Penning, J | 1 |
| Dusci, LJ; Fairclough, D; Goucke, CR; Ilett, KF; Van Leeuwen, S | 1 |
| Lehmann, DF | 1 |
| Coluzzi, F; Mattia, C | 1 |
| Guay, DR | 1 |
| Anderson, PO; Lane, JR; Nguyen, N; Rafie, S; Rossi, SS; Sauberan, JB; Stellwagen, LM | 1 |
| Bijur, PE; Chang, AK; Gallagher, EJ | 1 |
| Koren, G | 1 |
| Chan, PS; Forero, M; Restrepo-Garces, CE | 1 |
| Brunelli, C; Caraceni, A; Pigni, A | 1 |
| Davis, J; Reimer, EJ; Whyte, E; Whyte, S; Winton, P | 1 |
| Heath, TD; Krugner-Higby, L; Schmidt, JR; Smith, LJ; Sullivan, R | 1 |
| Bell, MC; Dampier, CD; Hsu, L; Keefer, J; Kim, HY; Krishnamurti, L; Mack, AK; McClish, D; McKinlay, SM; Miller, ST; Minniti, CP; Osunkwo, I; Seaman, P; Smith, WR; Telen, MJ; Wager, CG; Weiner, DL | 1 |
| Apfelbaum, SM; Burbage, M; Kircher, S; Kirsch, K; Lofwall, M; Passik, S; Zacny, J | 1 |
| Giesecke, T; Ringe, JD; Schäfer, S; Wimmer, AM | 1 |
| McFadden, KA; Moossy, JJ; Ortiz, V; Tomycz, ND; Urgo, L | 1 |
| Mercadante, S | 2 |
| Brody, J; Hardin, C; LeBaron, V; Lee, EM; Snyder, L | 1 |
| Cook, A; Gordon, MA; Goytizolo, E; Liu, SS; Ma, Y; Maalouf, D; Marcello, D; Memstoudis, SG; Memtsoudis, SG; Movahedi, R; Reid, S; Urban, M; Wukovits, B; Yadeau, JT | 1 |
| Rapoport, R; Rauck, R; Thipphawong, J | 1 |
| Bebarta, VS; Valtier, S | 1 |
| Baker, BB; Johnson, SM; Lahner, LL; Mans, C; Sladky, KK | 1 |
| Bertin, P; Bonnet, C; Coyral, D; Grilo, RM; Scotto di Fazano, C; Treves, R; Vergne, P | 1 |
| Quigley, C; Wiffen, P | 1 |
| Bonney, IM; Carr, DB; Hasirci, V; Lipkowski, AW; Sendil, D; Wise, DL | 1 |
| Ackerman, LL; Follett, KA; Rosenquist, RW | 1 |
| Altunay, H; Hasirci, V; Sendil-Keskin, D; Wise, DL | 1 |
| DAW, RH; MURRAY, A; SWERDLOW, M | 1 |
| HOMI, J; WASMUTH, CE | 1 |
| LEE, WJ; STEINHAUS, JE | 1 |
| CASS, LJ; FREDERIK, WS | 1 |
| WANG, RI | 1 |
| Cohen, MR | 1 |
| Bonney, I; Carr, DB; Goudas, LC; Hasirci, V; Shuster, L; Wise, DL | 1 |
| Sohn, W | 1 |
| Dahl, JB; Hoke, F; Maloney, A; Petersen, KL; Rowbotham, MC | 1 |
| Reiter, E | 1 |
| Pillai, A; Stockler, M; Vardy, J; Warr, D | 1 |
| Myers-Phariss, S; Perlman, KM; Rhodes, JC | 1 |
| Carson, S; Chung, KS; Glassman, D; Vadivelu, N | 1 |
| Dunn, E; McCartney, C; Peng, P; Rudich, Z | 1 |
| Sittig, HB | 2 |
| Ashby, M; Good, P; Goodchild, C; Jackson, K; Tullio, F | 1 |
| Diaz, NT; Grouper, S; Marcus, RJ; McCarthy, RJ; Patel, R; Peaceman, AM; Robles, C; Scavone, BM; Sherwani, SS; Sproviero, MT; Sullivan, JT; Wong, CA; Yaghmour, E; Yilmaz, M | 1 |
| Hagen, NA; Murray, A | 1 |
| Buckley, BJ; Grosset, AB; Reder, RF; Roberts, MS; Shi, M; Swanton, RE; Woodson, ME | 1 |
| Figge, V; Junker, U | 2 |
| Lindena, G; Müller-Busch, HC; Tietze, K; Woskanjan, S | 1 |
| Ganesh, A; Maxwell, LG; Rose, JB | 1 |
| Hasirci, V; Keskin, DS; Wise, DL | 1 |
| Buckley, BJ; Kwarcinski, MA; Shi, M; Weinstein, SM | 1 |
| Golianu, B; Lin, YC | 1 |
| Bijur, PE; Chang, AK; Gallagher, EJ; Kenny, MK; Meyer, RH; Solorzano, C | 1 |
| Cheung, RJ; Lee, KC; Patel, S; Roshan, VR | 1 |
| Berdine, HJ; Nesbit, SA | 1 |
| Buechler, NL; Eisenach, JC; Kim, SA; Martin, TJ; Porreca, F | 1 |
| Robertson, SA; Wegner, K | 1 |
| Häring, HU; Knaus-Dittmann, D; Mörike, K; Müssig, K; Schmidt, H | 1 |
| Clemens, KE; Klaschik, E | 1 |
| Smith, LH | 1 |
| Bozkaya, D; Caro, JJ; Dubois, D; Fleischmann, J; Sabatowski, R; Ward, A | 1 |
| Hale, M; Khanna, S; Thipphawong, J; Tudor, IC | 1 |
| Khanna, S; Moulin, D; Rauck, RL; Thipphawong, J; Tudor, IC; Wallace, M | 1 |
| Friedrichsdorf, SJ; Kang, TI | 1 |
| Giesecke, T; Sabatowski, R | 1 |
| Anders, MJ; Bone, LB; Jensen, EJ; Manka, MA; Mutty, CE | 1 |
| Nadstawek, J; Wartenberg, HC; Wirz, S | 1 |
| Kumar, MG; Lin, S | 1 |
| Eipe, N; Kay, J | 1 |
| Black, D; Caplan, YH; Cone, EJ; Moser, F; Robert, T | 1 |
| Bruera, E; Hanson, J; Pereira, J; Tarumi, Y; Watanabe, S | 1 |
| Güttler, K; Sabatowski, R | 1 |
| Baskerville, JC; Brands, B; Gowdey, CW; Herne, R; Hirst, M | 1 |
| Sheidler, UR | 1 |
| Chambers, FA; MacSullivan, R; McCarroll, M | 1 |
| Babul, N; Darke, AC; Dhaliwal, H; Hagen, N; Harsanyi, Z; Hays, H; Thirlwell, M | 1 |
| Boiskin, M; Bruera, E; Fainsinger, R; Schoeller, T | 1 |
| Hays, H; Mayo, P | 1 |
| Allan, S; Champion, P; Der, L; MacDonald, N | 1 |
| Bruera, E; Fainsinger, RL; Inturrisi, C; Spachynski, K; Suarez-Almazor, M; Watanabe, S | 1 |
| Buckley, P; Chapman, CR; Dunbar, PJ; Gavrin, JR; Sanders, JE | 1 |
| Brown, M; Charron, M; Mirro, J; Rowland, P | 1 |
| Bruera, E; Mount, B; Scott, J; Sloan, P; Suarez-Almazor, M | 1 |
| Belzile, M; Bruera, E; Hanson, J; Kuehn, N; Pereira, J; Watanabe, S | 1 |
| Archer, S; Bidlack, JM; Gatch, MB; Mello, NK; Negus, SS | 1 |
| Bruera, E; Fan, D; Vigano', A | 1 |
| Berde, CB; Collins, JJ; Geake, J; Grier, HE; Houck, CS; Thaler, HT; Twum-Danso, NY; Weinstein, HJ | 1 |
| Bossard, RF; Singh, H; White, PF; Yeatts, RW | 1 |
| Babul, N; Hagen, NA | 1 |
| Borsook, D; Chandler, SW; Manfredi, PL; Payne, R | 1 |
| Buckley, FP; Chapman, CR; Dunbar, PJ; Gavrin, JR | 1 |
| Trinkle, R | 1 |
| Chapman, CR; Donaldson, GW; Hautman, B; Jacobson, RC | 1 |
| Bruera, E; Hanson, J; Lawlor, P; Turner, K | 1 |
| Belzile, M; Bruera, E; De Conno, F; Groff, L; Hanson, J; Pereira, J; Ripamonti, C | 1 |
| MacConnachie, AM | 1 |
| Deen, C; Dunlop, TJ; Lind, S; Prichard, JG; Voyle, RJ | 1 |
| Angst, MS; Brose, WG; Dyck, JB | 1 |
| Derby, SA | 1 |
| Dahl, JL; Gilson, AM; Joranson, DE; Ryan, KM | 1 |
| Charuvastra, VC; Compton, P; Kintaudi, K; Ling, W | 1 |
| McCaffery, M; Pasero, C | 1 |
| Casas, JR; Cherny, N; Conno, F; Hanks, GW; Hanna, M; Kalso, E; McQuay, HJ; Mercadante, S; Meynadier, J; Poulain, P; Radbruch, L; Ripamonti, C; Sawe, J; Twycross, RG; Ventafridda, V | 1 |
| Nelson, KA; Sarhill, N; Walsh, D | 1 |
| Deer, TR; Elsberry, DD; Hildebrand, KR | 1 |
| Habermann, TM; Inwards, DJ; Schroeder, G; Wilson, PR; Witzig, TE; Wolanskyj, AP | 1 |
| Laval, G; Mallaret, M; Sang, B; Villard, ML | 1 |
| Kefalianakis, F; Kugler, G; Kugler, M; van der Auwera, R | 1 |
| Derby, S; Fischberg, D; Kornick, C; Manfredi, PL; Moryl, N; Payne, R; Santiago-Palma, J | 1 |
| Kalso, E | 1 |
| Hasirci, V; Sendil, D; Wise, DL | 1 |
| Brookoff, D; Damask, MC; Dornseif, BE; Doyle, RT; Northfelt, DW; Palangio, M; Portenoy, RK | 1 |
| Beaver, WT; Houde, RW; Rogers, A; Wallenstein, SL | 1 |
| Pegelow, CH | 1 |
| Banning, A; Kaiser, F; Sjøgren, P | 1 |
| Coddington, JM; Gamble, GD; Milne, RJ | 1 |
| Bouquillon, AI; Kreeft, JH; Moulin, DE; Murray-Parsons, N | 1 |
| Foley, KM; Inturrisi, CE; Portenoy, RK | 1 |
| Neels, JT | 1 |
| McLaughlin-Hagan, M | 1 |
| Sawynok, J | 1 |
| Chance, WT; Nelson, JL | 1 |
| Coleman, RR; Lo, SL | 1 |
| Brenneis, C; Bruera, E; Chadwick, S; MacDonald, RN; Michaud, M | 1 |
| Brenneis, C; Bruera, E; MacDonald, RN | 1 |
| Cousins, MJ; Tanelian, DL | 2 |
| Camporesi, EM; Glass, PS; Quill, T; Reves, JG; Shafron, D | 1 |
| Adams, F; Cruz, L; Deachman, MJ; Zamora, E | 1 |
| Botros, S; Larson, DL; Lipkowski, AW; Portoghese, PS; Stark, PA; Takemori, AE | 1 |
| Alexander, GJ; Chatterjie, N; Wisniewski, HM | 1 |
| Rogers, AG | 1 |
| Kreuzer, H; Spiller, P | 1 |
| Abdel-Rahman, MA; Binks, R; Elliott, HW; Küng, W; Rapoport, H | 1 |
| Nasits, BJ | 1 |
39 review(s) available for hydromorphone and Pain
| Article | Year |
|---|---|
Recurrent Persistent Hiccups on Opioid Treatment: A Case Report and Literature Review.
Topics: Analgesics, Opioid; Codeine; Hiccup; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Pain | 2023 |
Palliative sedation: A safety net for the relief of refractory and intolerable symptoms at the end of life.
Topics: Aged; Analgesics; Conscious Sedation; Dehydration; Dyspnea; Humans; Hydromorphone; Hypnotics and Sedatives; Male; Methotrimeprazine; Midazolam; Multiple Myeloma; Multiple Organ Failure; Pain; Palliative Care; Phenobarbital; Propofol; Psychomotor Agitation; Sepsis; Terminal Care | 2019 |
Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
Topics: Administration, Cutaneous; Analgesics, Opioid; Cachexia; Canada; Female; Fentanyl; Humans; Hydromorphone; Middle Aged; Morphine; Neoplasms; Pain; Palliative Care | 2021 |
Morphine or hydromorphone: which should be preferred? A systematic review.
Topics: Administration, Intravenous; Adolescent; Analgesics, Opioid; Child; Child, Preschool; Humans; Hydromorphone; Infant; Infant, Newborn; Morphine; Nausea; Pain; Pruritus; Urinary Retention | 2021 |
Immunotherapy associated pain crisis and the haemophagocytic lymphohistiocytosis syndrome in advanced melanoma: Case report and review of the literature.
Topics: Adult; Female; Humans; Hydromorphone; Immunotherapy; Lymphohistiocytosis, Hemophagocytic; Melanoma; Pain | 2021 |
The Comparative Risk of Delirium with Different Opioids: A Systematic Review.
Topics: Aged; Analgesics, Opioid; Delirium; Humans; Hydromorphone; Meperidine; Morphine; Oxycodone; Pain; Pain Measurement; Risk Factors; Tramadol | 2017 |
Efficacy and feasibility of opioids for burn analgesia: An evidence-based qualitative review of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Mucosal; Administration, Oral; Analgesics, Opioid; Burns; Feasibility Studies; Fentanyl; Humans; Hydromorphone; Morphine; Mouth Mucosa; Oxycodone; Pain; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
What Parenteral Opioids to Use in Face of Shortages of Morphine, Hydromorphone, and Fentanyl.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Morphine; Nalbuphine; Pain | 2018 |
WITHDRAWN: Hydromorphone for acute and chronic pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Pain; Randomized Controlled Trials as Topic | 2013 |
Hydromorphone: evolving to meet the challenges of today's health care environment.
Topics: Analgesics, Opioid; Dosage Forms; Drug Administration Schedule; Humans; Hydromorphone; Opioid-Related Disorders; Pain; Pain Management; Patient Selection; United States | 2013 |
[New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
Topics: Administration, Oral; Analgesics, Opioid; Analgesics, Short-Acting; Drug Administration Schedule; Drug Approval; Fentanyl; Humans; Hungary; Hydromorphone; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Therapeutic Equivalency; Time Factors | 2015 |
Opioid Pharmacokinetics-Pharmacodynamics: Clinical Implications in Acute Pain Management in Trauma.
Topics: Analgesics, Opioid; Fentanyl; Humans; Hydromorphone; Morphine; Pain; Pain Management; Pain Measurement; Wounds and Injuries | 2016 |
Hydromorphone for cancer pain.
Topics: Adult; Analgesics, Opioid; Female; Humans; Hydromorphone; Male; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement; Randomized Controlled Trials as Topic | 2016 |
Analgesia in the surgical intensive care unit.
Topics: Acetaminophen; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Conduction; Anesthetics, Local; Clonidine; Critical Care; Cyclohexanecarboxylic Acids; Dexmedetomidine; Fentanyl; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydromorphone; Intensive Care Units; Ketamine; Lidocaine; Morphine; Pain; Pain Management; Pain Measurement; Pain, Postoperative; Physical Therapy Modalities | 2017 |
Equianalgesia: applying evidence-based practice guidelines.
Topics: Analgesia; Analgesics, Opioid; Codeine; Drug Monitoring; Evidence-Based Medicine; Humans; Hydromorphone; Methadone; Morphine; Neoplasms; Nurse's Role; Nursing Assessment; Oncology Nursing; Pain; Practice Guidelines as Topic; Therapeutic Equivalency; Treatment Outcome | 2008 |
[The role of hydromorphone in pain killing].
Topics: Analgesia; Analgesics, Opioid; Humans; Hydromorphone; Pain | 2008 |
Pediatric palliative care: use of opioids for the management of pain.
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Child; Delayed-Action Preparations; Fentanyl; Humans; Hydromorphone; Methadone; Morphine; Narcotics; Pain; Palliative Care | 2009 |
The pharmacokinetics of a long-acting OROS hydromorphone formulation.
Topics: Administration, Oral; Chronic Disease; Delayed-Action Preparations; Humans; Hydromorphone; Pain | 2010 |
OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.
Topics: Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Drug Interactions; Humans; Hydromorphone; Molecular Structure; Pain; Severity of Illness Index; Treatment Outcome | 2010 |
Use of hydromorphone, with particular reference to the OROS formulation, in the elderly.
Topics: Aged; Delayed-Action Preparations; Humans; Hydromorphone; Pain | 2010 |
Hydromorphone-OROS formulation.
Topics: Analgesics, Opioid; Animals; Delayed-Action Preparations; Humans; Hydromorphone; Pain; Pain, Postoperative; Severity of Illness Index | 2010 |
OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
Topics: Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; Hydromorphone; Osmotic Pressure; Pain; Randomized Controlled Trials as Topic | 2010 |
Oral hydromorphone extended-release.
Topics: Administration, Oral; Aged; Analgesics, Opioid; Delayed-Action Preparations; Drug Administration Schedule; Humans; Hydromorphone; Osmotic Pressure; Pain | 2010 |
The role of hydromorphone in cancer pain treatment: a systematic review.
Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Pain; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2011 |
Extended-release hydromorphone (Exalgo) for pain.
Topics: Animals; Chemistry, Pharmaceutical; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Humans; Hydromorphone; Pain | 2011 |
Understanding and treating opioid addiction in a patient with cancer pain.
Topics: Adult; Analgesics, Opioid; Antineoplastic Agents; Brain; Cytarabine; Daunorubicin; Heroin Dependence; Hormones; Humans; Hydromorphone; Leukemia, Myeloid; Male; Pain | 2011 |
A systematic review of hydromorphone in acute and chronic pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Pain; Palliative Care | 2003 |
Hydromorphone.
Topics: Analgesics, Opioid; History, 20th Century; Humans; Hydromorphone; Neoplasms; Pain; Pharmaceutical Preparations; Substance-Related Disorders | 2005 |
Opioid safety: is your patient at risk for respiratory depression?
Topics: Adult; Analgesics, Opioid; Drug Monitoring; Female; Humans; Hydromorphone; Neoplasms; Ovarian Neoplasms; Pain; Respiratory Insufficiency; Risk Factors | 2007 |
The management of pain in children with life-limiting illnesses.
Topics: Analgesics, Opioid; Child; Chronic Disease; Codeine; Fentanyl; Humans; Hydromorphone; Ketamine; Methadone; Morphine; Nociceptors; Oxycodone; Pain; Pain Measurement; Severity of Illness Index | 2007 |
[Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone].
Topics: Activities of Daily Living; Administration, Oral; Analgesics, Opioid; Arthritis; Back Pain; Chronic Disease; Delayed-Action Preparations; Humans; Hydromorphone; Longitudinal Studies; Multicenter Studies as Topic; Osmosis; Pain; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Sleep; Surveys and Questionnaires; Time Factors; Treatment Outcome; World Health Organization | 2007 |
Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms.
Topics: Animals; Disease Management; Dosage Forms; Drug Administration Routes; Humans; Hydromorphone; Neoplasms; Pain; Pain Measurement | 2007 |
[Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Evidence-Based Medicine; Female; Humans; Hydromorphone; Immunity, Cellular; Male; Metabolic Clearance Rate; Middle Aged; Morphine; Oxycodone; Pain; Randomized Controlled Trials as Topic | 2008 |
Opioid rotation for cancer pain: rationale and clinical aspects.
Topics: Analgesics, Opioid; Fentanyl; Humans; Hydromorphone; Methadone; Morphine; Narcotics; Neoplasms; Pain | 1999 |
Hydromorphone: pharmacology and clinical applications in cancer patients.
Topics: Analgesics, Opioid; Drug Administration Routes; Humans; Hydromorphone; Neoplasms; Pain | 2001 |
Hydromorphone for acute and chronic pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Pain; Randomized Controlled Trials as Topic | 2002 |
[New opioid preparations in the treatment of pain].
Topics: Administration, Cutaneous; Analgesics, Opioid; Clinical Competence; Fentanyl; Humans; Hydromorphone; Oxycodone; Pain; Pain, Intractable; Tramadol | 1999 |
The therapeutic use of heroin: a review of the pharmacological literature.
Topics: Analgesia; Animals; Brain; Codeine; Depression; Euphoria; Female; Half-Life; Heroin; Humans; Hydromorphone; Kinetics; Liver; Male; Morphine; Morphine Derivatives; Neoplasms; Pain; Sex Factors; Solubility; Terminal Care; Water | 1986 |
Continuous Sc infusion of narcotics for the treatment of cancer pain: an update.
Topics: Heroin; Humans; Hydromorphone; Infusion Pumps; Morphine; Narcotics; Neoplasms; Pain | 1987 |
55 trial(s) available for hydromorphone and Pain
| Article | Year |
|---|---|
Comparison of hydromorphone and butorphanol for management of pain in equine patients undergoing elective arthroscopy: a randomized clinical trial.
Topics: Analgesics, Opioid; Animals; Arthroscopy; Butorphanol; Horses; Hydromorphone; Pain; Pain Measurement | 2022 |
Morphine and Hydromorphone Effects, Side Effects, and Variability: A Crossover Study in Human Volunteers.
Topics: Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Hydromorphone; Miosis; Morphine; Pain; Pain, Postoperative; Respiratory Insufficiency | 2023 |
Dexamethasone and dexmedetomidine as adjuvants to ropivacaine do not prolong analgesia in wound infiltration for lumbar spinal fusion: a prospective randomized controlled study.
Topics: Adult; Agnosia; Analgesia; Analgesics, Opioid; Dexamethasone; Dexmedetomidine; Humans; Hydromorphone; Lumbar Vertebrae; Pain; Prospective Studies; Ropivacaine; Spinal Fusion | 2023 |
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model.
Topics: Adult; Analgesics, Opioid; Cannabinoids; Double-Blind Method; Dronabinol; Humans; Hydromorphone; Laboratories; Pain | 2021 |
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Cancer Pain; Humans; Hydromorphone; Neoplasms; Pain | 2021 |
Analgesic Efficacy and Safety of Hydromorphone in Chinchillas (
Topics: Analgesics, Opioid; Animals; Chinchilla; Cross-Over Studies; Female; Hydromorphone; Laboratory Animal Science; Male; Pain; Pain Measurement | 2018 |
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
Topics: Adult; Analgesia; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Female; Humans; Hydromorphone; Male; Opioid-Related Disorders; Pain; Treatment Outcome | 2019 |
The antinociceptive effects of intravenous administration of three doses of butorphanol tartrate or naloxone hydrochloride following hydromorphone hydrochloride to healthy conscious cats.
Topics: Administration, Intravenous; Analgesics, Opioid; Animals; Butorphanol; Cats; Cross-Over Studies; Drug Therapy, Combination; Female; Hydromorphone; Naloxone; Pain; Pain Measurement; Random Allocation; Skin Temperature | 2019 |
Evaluation of thermal antinociceptive effects after intramuscular administration of hydromorphone hydrochloride to American kestrels (Falco sparverius).
Topics: Analgesics, Opioid; Animals; Bird Diseases; Cross-Over Studies; Falconiformes; Female; Hot Temperature; Hydromorphone; Injections, Intramuscular; Male; Pain | 2013 |
Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain; Pain Measurement; Sample Size; Treatment Outcome; Young Adult | 2014 |
No correlation between body size and hydromorphone analgesia in obese patients in ED.
Topics: Analgesics, Opioid; Body Size; Emergency Service, Hospital; Female; Humans; Hydromorphone; Male; Obesity; Pain; Prospective Studies | 2015 |
Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine.
Topics: Chronic Disease; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Pain; Prevalence; Reproducibility of Results; Sensitivity and Specificity; Substance Abuse Detection; Urinalysis | 2008 |
Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Emergency Service, Hospital; Female; Humans; Hydromorphone; Male; Morphine; Pain; Pain Measurement; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Critical Pathways; Drug Administration Schedule; Emergency Service, Hospital; Female; Humans; Hydromorphone; Infusions, Intravenous; Male; Middle Aged; New York; Pain; Pain Measurement; Patient Satisfaction | 2009 |
A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury.
Topics: Acute Disease; Administration, Intranasal; Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Fractures, Bone; Humans; Hydromorphone; Male; Pain; Pain Measurement; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome; Wounds and Injuries | 2010 |
Antinociceptive effects of epidural administration of hydromorphone in conscious cats.
Topics: Animals; Blood Pressure; Cat Diseases; Cats; Cross-Over Studies; Female; Hydromorphone; Injections, Epidural; Male; Pain; Skin Temperature | 2009 |
[Controlled release hydromorphone for visceral, somatic and neuropathic pain].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Data Interpretation, Statistical; Delayed-Action Preparations; Female; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Pain; Pain Measurement; Patient Compliance; Switzerland; Time Factors | 2010 |
Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Chromatography, High Pressure Liquid; Chronic Disease; Drug Stability; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Morphine; Pain; Pain Measurement; Pilot Projects | 2010 |
Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain.
Topics: Adult; Analgesics, Opioid; Clinical Protocols; Emergency Service, Hospital; Female; Humans; Hydromorphone; Injections, Intravenous; Male; Pain; Pain Measurement; Treatment Outcome | 2011 |
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.
Topics: Adolescent; Adult; Age Factors; Analgesia, Patient-Controlled; Analgesics, Opioid; Child; Dose-Response Relationship, Drug; Early Termination of Clinical Trials; Female; Hemoglobin SC Disease; Humans; Hydromorphone; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Morphine; Pain; Vascular Diseases; Young Adult | 2011 |
Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses.
Topics: Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Germany; Humans; Hydromorphone; Male; Osteoarthritis; Osteoporosis; Pain; Pain Measurement; Treatment Outcome | 2012 |
Nerve stimulator versus ultrasound guidance for placement of popliteal catheters for foot and ankle surgery.
Topics: Adult; Aged; Amides; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Ankle; Catheterization; Double-Blind Method; Electric Stimulation; Female; Foot; Hospitals, University; Humans; Hydromorphone; Length of Stay; Male; Middle Aged; Nerve Block; Pain; Pain Measurement; Prospective Studies; Ropivacaine; Sciatic Nerve; Ultrasonography, Interventional | 2012 |
Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS® hydromorphone ER in patients with moderate to severe pain associated with chronic osteoarthritis.
Topics: Aged; Analgesics, Opioid; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Observation; Osteoarthritis; Pain; Pain Measurement; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome | 2013 |
Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider turtles (Trachemys scripta elegans).
Topics: Animals; Buprenorphine; Cross-Over Studies; Dose-Response Relationship, Drug; Hot Temperature; Hydromorphone; Pain; Time Factors; Turtles | 2012 |
Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Chronic Disease; Clonidine; Drug Therapy, Combination; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Pain; Treatment Outcome | 2003 |
A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization.
Topics: Adult; Analgesics, Opioid; Anticonvulsants; Capsaicin; Double-Blind Method; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Hot Temperature; Humans; Hydromorphone; Hyperalgesia; Lamotrigine; Pain; Pain Measurement; Piperidines; Remifentanil; Triazines | 2003 |
Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Humans; Hydromorphone; Middle Aged; Morphine; Neoplasms; Pain; Placebos; Quality of Life | 2004 |
Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients.
Topics: Analgesics; Chronic Disease; Clonidine; Complex Mixtures; Drug Combinations; Drug Stability; Drug Storage; Humans; Hydromorphone; Infusion Pumps, Implantable; Injections, Spinal; Pain; Quality Assurance, Health Care | 2004 |
The risk of cesarean delivery with neuraxial analgesia given early versus late in labor.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Analgesics, Opioid; Cesarean Section; Female; Fentanyl; Humans; Hydromorphone; Infant, Newborn; Injections, Intravenous; Injections, Spinal; Labor, Obstetric; Multivariate Analysis; Pain; Pregnancy; Pregnancy Outcome; Risk; Time Factors | 2005 |
Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Terminal Care | 2005 |
[Controlled-release hydromorphone in elderly patients with severe pain of different etiologies. Results of an observational study].
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Treatment Outcome | 2005 |
Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial.
Topics: Adult; Aged; Analgesics, Opioid; Antiemetics; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Pain; Pain Measurement; Prospective Studies; Treatment Outcome | 2006 |
Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats.
Topics: Analgesics, Opioid; Animals; Cats; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hydromorphone; Infusions, Intravenous; Male; Pain; Sensory Thresholds; Skin Temperature | 2007 |
Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Female; Hip; Humans; Hydromorphone; Knee; Male; Middle Aged; Osteoarthritis; Oxycodone; Pain | 2007 |
Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Surveys and Questionnaires; Titrimetry; Treatment Outcome | 2007 |
Femoral nerve block for diaphyseal and distal femoral fractures in the emergency department.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthesia, Local; Bupivacaine; Female; Femoral Fractures; Femoral Nerve; Humans; Hydromorphone; Male; Middle Aged; Nerve Block; Pain; Pain Measurement; Trauma Centers | 2007 |
Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Constipation; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Nausea; Neoplasms; Pain; Pain Measurement; Prospective Studies; Risk Factors; Vomiting | 2008 |
Evidence that morphine is metabolized to hydromorphone but not to oxymorphone.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Oxymorphone; Pain | 2008 |
A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Health Status Indicators; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Oxycodone; Pain; Pain Measurement | 2008 |
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain.
Topics: Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement | 1994 |
Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain.
Topics: Aged; Analgesics, Opioid; Capsules; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Neoplasms; Pain; Prospective Studies; Suppositories | 1995 |
A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group.
Topics: Adult; Aged; Canada; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Palliative Care | 1996 |
Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
Topics: Adolescent; Analgesia, Patient-Controlled; Analgesics, Opioid; Analysis of Variance; Child; Cross-Over Studies; Double-Blind Method; Humans; Hydromorphone; Inflammation; Morphine; Mucous Membrane; Pain; Pain Measurement; Therapeutic Equivalency; Treatment Outcome | 1996 |
Effects of ketorolac versus bupivacaine coadministration during patient-controlled hydromorphone epidural analgesia after thoracotomy procedures.
Topics: Aged; Analgesia, Epidural; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Bupivacaine; Humans; Hydromorphone; Ketorolac; Lung; Middle Aged; Pain; Postoperative Complications; Postoperative Period; Self Administration; Thoracotomy; Tolmetin | 1997 |
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain.
Topics: Analgesics, Opioid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Oxycodone; Pain | 1997 |
Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Bone Marrow Transplantation; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Morphine; Mouth Mucosa; Pain; Pain Measurement; Prospective Studies; Stomatitis; Therapeutic Equivalency | 1996 |
Differences among patients in opioid self-administration during bone marrow transplantation.
Topics: Adolescent; Adult; Analgesics, Opioid; Bone Marrow Transplantation; Double-Blind Method; Humans; Hydromorphone; Middle Aged; Morphine; Pain; Pattern Recognition, Visual; Self Administration; Stomatitis; Transplantation Conditioning | 1997 |
Use of combined oral narcotic and benzodiazepine for control of pain associated with bone marrow examination.
Topics: Administration, Oral; Adult; Analgesia; Benzodiazepines; Bone Marrow Examination; Drug Therapy, Combination; Female; Humans; Hydromorphone; Lorazepam; Male; Middle Aged; Narcotics; Pain; Pain Measurement; Pain Threshold; Premedication | 1999 |
Pain responses in methadone-maintained opioid abusers.
Topics: Adult; Cold Temperature; Drug Interactions; Female; Humans; Hydromorphone; Ketorolac; Male; Methadone; Middle Aged; Opioid-Related Disorders; Pain; Pain Measurement; Pain Threshold; Pressure; Reaction Time | 2000 |
A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Opioid; Anti-Anxiety Agents; Anxiety; Biopsy; Bone Marrow; Double-Blind Method; Female; Humans; Hydromorphone; Lorazepam; Lymphoma; Male; Middle Aged; Pain; Premedication; Prospective Studies | 2000 |
Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Female; Fentanyl; Humans; Hydromorphone; Levorphanol; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain; Patient Satisfaction; Prospective Studies | 2002 |
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Titrimetry | 2002 |
Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer.
Topics: Administration, Oral; Adult; Aged; Analgesics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hydromorphone; Injections, Intramuscular; Male; Middle Aged; Morphine; Neoplasms; Oxymorphone; Pain; Placebos; Time Factors | 1977 |
Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain.
Topics: Aged; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Hydromorphone; Infusion Pumps, Implantable; Infusions, Intravenous; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Pain; Palliative Care; Severity of Illness Index; Time Factors | 1991 |
Evaluation of pentamorphone in humans: a new potent opiate.
Topics: Analgesics; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Pain; Respiration; Sensory Thresholds | 1989 |
127 other study(ies) available for hydromorphone and Pain
| Article | Year |
|---|---|
Phlegmasia cerulea dolens causing compartment syndrome.
Topics: Compartment Syndromes; Edema; Female; Humans; Hydromorphone; Lidocaine; Middle Aged; Pain; Thrombophlebitis; Venous Thrombosis | 2022 |
Nano-Carbon-Based Application of Parecoxib Sodium Combined with Hydromorphone in Preventing Anesthesia Hyperalgesia Caused by Remifentanil after Thyroidectomy.
Topics: Analgesics, Opioid; Anesthesia; Humans; Hydromorphone; Hyperalgesia; Isoxazoles; Pain; Piperidines; Remifentanil; Thyroidectomy | 2022 |
Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Topics: Adult; Analgesics, Opioid; Codeine; Cohort Studies; Female; Humans; Hydrocodone; Hydromorphone; Infant, Newborn; Infant, Newborn, Diseases; Methadone; Morphine; Neonatal Abstinence Syndrome; Oxycodone; Pain; Pregnancy; Prescriptions; Substance Withdrawal Syndrome; Tramadol; United States | 2022 |
CYP2D in the brain impacts oral hydrocodone analgesia in vivo.
Topics: Analgesia; Analgesics, Opioid; Animals; Brain; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Hydrocodone; Hydromorphone; Male; Pain; Propranolol; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2022 |
Analgesic effect of butorphanol tartrate combined with hydromorphone on patients with cesarean section: A prospective cohort study.
Topics: Butorphanol; Cesarean Section; Female; Humans; Hydromorphone; Infant, Newborn; Jaundice, Neonatal; Pain; Pregnancy; Prospective Studies | 2022 |
Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
Topics: Analgesia, Patient-Controlled; Anemia, Sickle Cell; Humans; Hydromorphone; Pain; Pain Management; Retrospective Studies; Volatile Organic Compounds | 2023 |
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Hydromorphone; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain | 2023 |
Managing opioid waste, cost, and opportunity for drug diversion in the emergency department.
Topics: Analgesics, Opioid; Emergency Service, Hospital; Humans; Hydromorphone; Morphine; Pain; Prescription Drug Diversion | 2023 |
Pain management in patients with chronic kidney disease and end-stage kidney disease.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Hydromorphone; Kidney Failure, Chronic; Oxycodone; Pain; Pain Management; Receptors, Opioid, mu; Renal Insufficiency, Chronic | 2020 |
High-dose intravenous hydromorphone for patients who use opioids in the hospital setting: time to reduce the barriers.
Topics: Analgesics, Opioid; Canada; Hospitals; Humans; Hydromorphone; Pain | 2021 |
Predictors of Response in Emergency Department Patients Receiving Intravenous Opioids for Severe Pain.
Topics: Adult; Analgesics, Opioid; Case-Control Studies; Emergency Service, Hospital; Female; Humans; Hydromorphone; Infusions, Intravenous; Male; Middle Aged; Morphine; Pain; Pain Management; Pain Measurement; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index | 2017 |
Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
Topics: Analgesics, Opioid; Chromatography, High Pressure Liquid; False Negative Reactions; Humans; Hydromorphone; Illicit Drugs; Long-Term Care; Pain; Patient Compliance; Reference Standards; Retrospective Studies; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2017 |
IV prochlorperazine + diphenhydramine improved migraine pain relief more than IV hydromorphone in the ED.
Topics: Diphenhydramine; Humans; Hydromorphone; Migraine Disorders; Pain; Prochlorperazine | 2018 |
Hydromorphone Conversion Dilemma: A Millennial Problem.
Topics: Administration, Intravenous; Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Pain | 2018 |
Transition From Continuous Infusion Fentanyl to Hydromorphone in Critically Ill Patients.
Topics: Adult; Analgesics, Opioid; Critical Care; Critical Illness; Female; Fentanyl; Humans; Hydromorphone; Hypnotics and Sedatives; Male; Middle Aged; Pain; Pain Management; Prospective Studies | 2020 |
Opioid Administration and Prescribing in Older Adults in U.S. Emergency Departments (2005-2015).
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Emergency Service, Hospital; Female; Health Care Surveys; Humans; Hydromorphone; Male; Pain; Patient Discharge; Practice Patterns, Physicians'; United States | 2018 |
Patient Preference for Pain Medication in the Emergency Department Is Associated with Non-fatal Overdose History.
Topics: Adult; Analgesics, Opioid; Drug Overdose; Emergency Service, Hospital; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Pain; Patient Preference | 2018 |
Parenteral Opioid Shortage - Treating Pain during the Opioid-Overdose Epidemic.
Topics: Administration, Intravenous; Analgesics, Opioid; Drug Compounding; Drug Overdose; Fentanyl; Government Regulation; Humans; Hydromorphone; Legislation, Drug; Morphine; Opioid-Related Disorders; Pain; Practice Guidelines as Topic; United States | 2018 |
Evaluation of the thermal antinociceptive effects and pharmacokinetics of hydromorphone hydrochloride after intramuscular administration to cockatiels (Nymphicus hollandicus).
Topics: Analgesics, Opioid; Animals; Chromatography, Liquid; Cockatoos; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Hot Temperature; Hydromorphone; Hypnotics and Sedatives; Male; Pain; Tandem Mass Spectrometry; Time Factors | 2018 |
National opioid prescribing trends in emergency departments by provider type: 2005-2015.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Child, Preschool; Emergency Service, Hospital; Female; Health Care Surveys; Humans; Hydromorphone; Infant; Infant, Newborn; Logistic Models; Male; Middle Aged; Morphine; Nurse Practitioners; Pain; Physician Assistants; Physicians; Practice Patterns, Physicians'; United States; Young Adult | 2019 |
Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990-2016.
Topics: Analgesics, Opioid; Europe; European Union; Fentanyl; Humans; Hydromorphone; Meperidine; Morphine; Oxycodone; Pain; Practice Patterns, Physicians'; Regression Analysis; United States | 2019 |
The Development of a Macromolecular Analgesic for Arthritic Pain.
Topics: Acrylamides; Analgesics; Analgesics, Opioid; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Drug Discovery; Endocytosis; Hydromorphone; Male; Mice; Pain; Phagocytosis; Polymers; Prodrugs; Rats; Rats, Inbred Lew; RAW 264.7 Cells; Tissue Distribution; Treatment Outcome | 2019 |
In vivo activity of norhydrocodone: an active metabolite of hydrocodone.
Topics: Analgesics, Opioid; Animals; Binding, Competitive; Hydrocodone; Hydromorphone; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Ligands; Male; Mice; Mice, Inbred Strains; Pain; Protein Binding; Receptors, Opioid, mu; Seizures | 2013 |
Observations on the urine metabolic profile of codeine in pain patients.
Topics: Analgesics, Opioid; Biotransformation; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Monitoring; Enzyme Inhibitors; Humans; Hydrocodone; Hydromorphone; Pain; Retrospective Studies; Risk Assessment; Risk Factors; Urinalysis | 2014 |
Chemical coping versus pseudoaddiction in patients with cancer pain.
Topics: Adaptation, Psychological; Adult; Analgesics, Opioid; Comorbidity; Head and Neck Neoplasms; Humans; Hydrocodone; Hydromorphone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Opioid-Related Disorders; Pain | 2014 |
What is your gut feeling about opioid rotation?
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Biological Availability; Delayed-Action Preparations; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Intestinal Obstruction; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain; Pain Management; Quality of Life | 2015 |
Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010.
Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Emergency Service, Hospital; Female; Health Care Surveys; Humans; Hydrocodone; Hydromorphone; Male; Middle Aged; Morphine; Oxycodone; Pain; Pain Measurement; Patient Discharge; Practice Patterns, Physicians'; United States | 2014 |
Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
Topics: Analgesics, Opioid; Animals; Biological Availability; Half-Life; Hydromorphone; Injections, Intramuscular; Injections, Intravenous; Kinetics; Macaca mulatta; Male; Pain | 2014 |
Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Antibodies, Monoclonal; Child; Child, Preschool; Dexmedetomidine; Drug Therapy, Combination; Female; Follow-Up Studies; Gangliosides; Humans; Hydromorphone; Immunotherapy; Male; Neuroblastoma; Pain; Pain Management; Prognosis | 2015 |
The Benefits of Authorized Agent Controlled Analgesia (AACA) to Control Pain and Other Symptoms at the End of Life.
Topics: Aged; Analgesics; Attitude of Health Personnel; Consumer Behavior; Family; Female; Follow-Up Studies; Hospitals, Community; Humans; Hydromorphone; Length of Stay; Male; Morphine; Pain; Pain Management; Pain Measurement; Palliative Care; Self Care; Terminal Care | 2015 |
ED ultrasound-guided posterior tibial nerve blocks for calcaneal fracture analagesia.
Topics: Accidental Falls; Analgesics, Opioid; Calcaneus; Fractures, Bone; Humans; Hydromorphone; Male; Middle Aged; Nerve Block; Pain; Tibial Nerve; Treatment Outcome; Ultrasonography, Interventional | 2016 |
The use of topical opioids for systemic pain management.
Topics: Administration, Topical; Aged, 80 and over; Analgesics, Opioid; Chronic Disease; Dose-Response Relationship, Drug; Drug Compounding; Humans; Hydromorphone; Male; Pain | 2008 |
Femoral nerve block for diaphyseal and distal femoral fractures in the emergency department.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthesia, Local; Bupivacaine; Female; Femoral Fractures; Femoral Nerve; Humans; Hydromorphone; Male; Middle Aged; Nerve Block; Pain; Pain Measurement; Trauma Centers | 2008 |
Safety and efficacy of rapid titration using 1mg doses of intravenous hydromorphone in emergency department patients with acute severe pain: the "1+1" protocol.
Topics: Adult; Clinical Protocols; Emergency Service, Hospital; Female; Humans; Hydromorphone; Infusions, Intravenous; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Treatment Outcome | 2009 |
The "1+1" protocol: risks, benefits, and alternatives.
Topics: Blood Gas Analysis; Critical Pathways; Drug Administration Schedule; Emergency Service, Hospital; Humans; Hydromorphone; Infusions, Intravenous; Narcotics; Nursing Care; Oximetry; Pain | 2009 |
Unexpected urine drug testing results in a hospice patient on high-dose morphine therapy.
Topics: Adult; Analgesics, Opioid; Fatal Outcome; Female; Hospice Care; Humans; Hydromorphone; Morphine; Neoplasm Invasiveness; Neoplasm Metastasis; Pain; Uterine Cervical Neoplasms | 2009 |
Commentary.
Topics: Analgesics, Opioid; Female; Humans; Hydromorphone; Morphine; Pain; Substance Abuse Detection; Substance-Related Disorders; Uterine Cervical Neoplasms | 2009 |
Commentary.
Topics: Analgesics, Opioid; Diagnosis, Differential; Female; Humans; Hydromorphone; Morphine; Morphine Dependence; Pain; Patient-Centered Care; Substance Abuse Detection; Terminal Care; Uterine Cervical Neoplasms | 2009 |
Opioid conversions and patient-controlled analgesia parameters in opioid-dependent patients.
Topics: Administration, Oral; Analgesia, Patient-Controlled; Analgesics, Opioid; Dose-Response Relationship, Drug; Humans; Hydromorphone; Infusions, Intravenous; Morphine; Opioid-Related Disorders; Pain; Pain, Postoperative | 2010 |
Teaching from catastrophe: using therapeutic misadventures from hydromorphone to teach key principles in clinical pharmacology.
Topics: Adult; Analgesics, Opioid; Curriculum; Death; Drug Interactions; Education, Medical; Humans; Hydromorphone; Individuality; Male; Medication Errors; Middle Aged; Monitoring, Physiologic; Pain; Pharmacology, Clinical; Young Adult | 2011 |
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Female; Humans; Hydrocodone; Hydromorphone; Milk, Human; Pain; Postpartum Period; Pregnancy; Young Adult | 2011 |
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain.
Topics: Analgesics, Opioid; Female; Humans; Hydrocodone; Hydromorphone; Infant, Newborn; Milk, Human; Pain; Postpartum Period | 2011 |
Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion.
Topics: Analgesics, Opioid; Humans; Hydromorphone; Hyperalgesia; Infusions, Intravenous; Ketamine; Male; Middle Aged; Myoclonus; Pain | 2012 |
Dexmedetomidine for co-analgesia in chemotherapy-induced severe enterocolitis.
Topics: Adrenal Gland Neoplasms; Analgesics, Non-Narcotic; Analgesics, Opioid; Antineoplastic Agents; Child, Preschool; Dexmedetomidine; Enterocolitis; Female; Humans; Hydromorphone; Infusions, Intravenous; Neuroblastoma; Pain; Pain Measurement | 2011 |
Epidural administration of liposome-encapsulated hydromorphone provides extended analgesia in a rodent model of stifle arthritis.
Topics: Analgesia, Epidural; Analysis of Variance; Animals; Arthritis; Delayed-Action Preparations; Drug Delivery Systems; Hydromorphone; Liposomes; Motor Activity; Pain; Pain Measurement; Rats; Spinal Cord; Stifle | 2011 |
Management of symptomatic intrathecal catheter-associated inflammatory masses.
Topics: Adult; Aged; Analgesics, Opioid; Catheters; Female; Granuloma; Humans; Hydromorphone; Inflammation; Infusion Pumps, Implantable; Injections, Spinal; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Morphine; Nervous System Diseases; Neurosurgical Procedures; Pain; Reoperation; Retrospective Studies; Spine; Tomography, X-Ray Computed | 2012 |
The use of high doses of OROS hydromorphone in an acute palliative care unit.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Drug Substitution; Female; Humans; Hydromorphone; Male; Middle Aged; Pain; Pain Management; Palliative Care; Retrospective Studies | 2011 |
Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
Topics: Adult; Analgesics, Opioid; Colorectal Neoplasms; Fatal Outcome; Female; Humans; Hydromorphone; Infusions, Intravenous; Methadone; Neoplasm Metastasis; Pain; Palliative Care | 2011 |
Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers.
Topics: Administration, Oral; Analgesics, Opioid; Chromatography, Liquid; Dose-Response Relationship, Drug; Female; Humans; Hydrocodone; Hydromorphone; Limit of Detection; Male; Pain; Solid Phase Extraction; Substance Abuse Detection; Tandem Mass Spectrometry | 2012 |
Opioid rotation in the treatment of joint pain. A review of 67 cases.
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Joints; Morphine; Pain; Pain Measurement; Retrospective Studies; Rheumatic Diseases; Rheumatology; Treatment Outcome | 2002 |
Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats.
Topics: Analgesics; Animals; Bupivacaine; Drug Delivery Systems; Drug Implants; Enkephalins; Hydromorphone; Injections, Spinal; Lactic Acid; Male; Pain; Pain Measurement; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley | 2003 |
In vivo pain relief effectiveness of an analgesic-anesthetic carrying biodegradable controlled release rod systems.
Topics: Analgesics, Opioid; Anesthetics, Local; Animals; Behavior, Animal; Biocompatible Materials; Biodegradation, Environmental; Bupivacaine; Codeine; Drug Delivery Systems; Drug Implants; Female; Hydromorphone; Lactic Acid; Morphine; Pain; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
A study of postoperative pain.
Topics: Dextromoramide; Humans; Hydromorphone; Morphine; Pain; Pain, Postoperative; Phenazocine; Postoperative Care | 1963 |
A review of oxymorphone hydrochloride (Numorphan) analgesia employed for general surgery, including clinical experience with five hundred and twenty-eight patients.
Topics: Analgesia; Humans; Hydromorphone; Oxymorphone; Pain; Pain Management | 1961 |
EVALUATION OF OPIATES FOR PAIN AND PREMEDICATION.
Topics: Analgesics, Opioid; Humans; Hydromorphone; Meperidine; Morphine; Pain; Preoperative Care; Toxicology | 1963 |
THE CONTROL OF SEVERE PAIN WITH ORAL OXYMORPHONE HYDROCHLORIDE.
Topics: Adolescent; Geriatrics; Humans; Hydromorphone; Meperidine; Oxymorphone; Pain; Toxicology | 1963 |
ANALGESICS FOR THE RELIEF OF PAIN. I. NARCOTIC ANALGESICS.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Codeine; Humans; Hydromorphone; Meperidine; Methadone; Morphine; Narcotics; Oxymorphone; Pain; Phenazocine; Piperidines | 1964 |
Oral vs. i.v. hydromorphone. Add a measure of caution.
Topics: Administration, Oral; Analgesics, Opioid; Drug Prescriptions; Female; Hodgkin Disease; Humans; Hydromorphone; Injections, Intravenous; Medication Errors; Pain; Therapeutic Equivalency | 2003 |
Antihyperalgesic effect of simultaneously released hydromorphone and bupivacaine from polymer fibers in the rat chronic constriction injury model.
Topics: Analgesics, Opioid; Animals; Bupivacaine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Drug Therapy, Combination; Hindlimb; Hot Temperature; Hydromorphone; Hyperalgesia; Lactic Acid; Ligation; Male; Pain; Pain Measurement; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2003 |
[Pain therapy with semisynthetic opioids. Patients have opioid-type side effects more rarely].
Topics: Administration, Oral; Analgesics, Opioid; Capsules; Clinical Trials as Topic; Humans; Hydromorphone; Multicenter Studies as Topic; Pain; Prospective Studies; Time Factors | 2003 |
[Pain therapy in patients with tumors. According to graduated schedule and hourly plan].
Topics: Analgesics, Opioid; Humans; Hydromorphone; Neoplasms; Pain; Time Factors | 2003 |
Personal accounts: a truly invisible handicap.
Topics: Analgesics, Opioid; History, 20th Century; Humans; Hydromorphone; Mental Health; Pain; Pain Measurement; Paresis; Quality of Life; Severity of Illness Index; Stroke; Substance-Related Disorders | 2004 |
A shift from demerol (meperidine) to dilaudid (hydromorphone) improves pain control and decreases admissions for patients in sickle cell crisis.
Topics: Anemia, Sickle Cell; Clinical Protocols; Emergency Service, Hospital; Humans; Hydromorphone; Meperidine; Pain; Pain Measurement; Patient Admission; Program Evaluation | 2004 |
Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia.
Topics: Humans; Hydromorphone; Hyperalgesia; Male; Methadone; Middle Aged; Narcotics; Neurotoxicity Syndromes; Pain | 2004 |
[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
Topics: Aged; Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Hydromorphone; Middle Aged; Pain; Pain Measurement; Quality of Life | 2004 |
[Pain reduced and quality of life improved by sustained-release hydromorphone. Results of an observational study].
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Patient Compliance; Quality of Life; Time Factors | 2004 |
Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dexamethasone; Drug Therapy, Combination; Humans; Hydromorphone; Ketamine; Ketorolac; Male; Middle Aged; Oxycodone; Pain; Prospective Studies | 2005 |
Palladone for chronic pain.
Topics: Biological Availability; Chronic Disease; Delayed-Action Preparations; Humans; Hydromorphone; Pain; Substance-Related Disorders | 2005 |
[Pain therapy. Extensive possibilities not adequately utilized].
Topics: Analgesics, Opioid; Clinical Trials as Topic; Germany; Humans; Hydromorphone; Pain; Palliative Care; Treatment Outcome | 2005 |
[Observational data in elderly pain patients show that fear of opioid therapy is unfounded].
Topics: Aged; Analgesics, Opioid; Delayed-Action Preparations; Fear; Humans; Hydromorphone; Middle Aged; Pain; Pain Measurement; Patient Acceptance of Health Care; Quality of Life; Randomized Controlled Trials as Topic; Treatment Refusal | 2005 |
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Topics: Aged; Ambulatory Care Facilities; Analgesics, Opioid; Buprenorphine; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization Review; Female; Fentanyl; Hospitals; Humans; Hydromorphone; Male; Middle Aged; Morphine; Oxycodone; Pain; Palliative Care; Prospective Studies; Treatment Outcome | 2005 |
Protracted pain following partial splenic embolization in an adolescent female with hypersplenism.
Topics: Adolescent; Analgesics, Opioid; Balloon Occlusion; Female; Humans; Hydromorphone; Hypersplenism; Pain; Splenomegaly; Tomography, X-Ray Computed | 2005 |
Pain control via opioid analgesic-local anesthetic loaded IPNs.
Topics: Analgesics, Opioid; Anesthetics, Local; Animals; Bupivacaine; Codeine; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Excipients; Female; Hydromorphone; Ligation; Morphine; Pain; Pain Measurement; Polyesters; Polyhydroxyethyl Methacrylate; Rats; Rats, Sprague-Dawley; Reaction Time; Sciatic Neuropathy; Solubility | 2004 |
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
[Delayed action and rapidly effective in combination. Hydromorphone--already a WHO stage 3 drug].
Topics: Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Hydromorphone; Neoplasms; Pain | 2006 |
Anesthesia and pain management for pediatric patients with dystrophic epidermolysis bullosa.
Topics: Adolescent; Anesthesia, General; Child; Child, Preschool; Conscious Sedation; Epidermolysis Bullosa Dystrophica; Female; Humans; Hydromorphone; Infant; Male; Methadone; Morphine; Pain; Perioperative Care; Postoperative Complications; Preoperative Care; Retrospective Studies | 2006 |
A myoclonic reaction with low-dose hydromorphone.
Topics: Drug Administration Schedule; Humans; Hydromorphone; Male; Middle Aged; Myoclonus; Pain | 2006 |
Equianalgesic dosing of opioids.
Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Fentanyl; Humans; Hydromorphone; Methadone; Pain; Therapeutic Equivalency | 2006 |
Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.
Topics: Adenosine; Analgesics, Opioid; Animals; Clonidine; Dose-Response Relationship, Drug; Fentanyl; Heroin; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Male; Methadone; Morphine; Neuralgia; Pain; Rats; Rats, Inbred F344; Self Administration | 2007 |
Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment.
Topics: Adrenal Insufficiency; Adult; Amenorrhea; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Pain | 2007 |
Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Female; Fentanyl; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Palliative Care; Patient Satisfaction; Retrospective Studies; Statistics, Nonparametric | 2007 |
Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Topics: Analgesics, Opioid; Chronic Disease; Cohort Studies; Cost-Benefit Analysis; Delayed-Action Preparations; Germany; Humans; Hydromorphone; Osteoarthritis; Oxycodone; Pain; Sleep; Treatment Outcome | 2007 |
Spontaneously breathing technique for opioid tolerance.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Inhalation; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Drug Tolerance; Fentanyl; Fractures, Bone; Humans; Humerus; Hydromorphone; Intubation, Intratracheal; Ketorolac; Male; Marijuana Abuse; Methyl Ethers; Opioid-Related Disorders; Orthopedic Procedures; Pain; Respiration; Sevoflurane | 2008 |
Sparingly-soluble narcotic zinc tannates cause protracted analgesia in rats.
Topics: Analgesics, Opioid; Animals; Body Weight; Delayed-Action Preparations; Heroin; Hydrolyzable Tannins; Hydromorphone; Male; Pain; Rats; Solubility; Time Factors; Zinc | 1980 |
Equianalgesic dosing: oral to i.v. conversions.
Topics: Administration, Oral; Aged; Humans; Hydromorphone; Infusions, Intravenous; Lung Neoplasms; Male; Mathematics; Pain; Therapeutic Equivalency | 1993 |
Polyarthralgia and amenorrhea as a complication of intrathecally infused morphine and Dilaudid in the treatment of chronic benign back pain.
Topics: Adult; Amenorrhea; Female; Humans; Hydromorphone; Joint Diseases; Low Back Pain; Morphine; Pain | 1994 |
Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Captopril; Cognition Disorders; Coma; Female; Humans; Hydromorphone; Hypertension; Kidney Failure, Chronic; Pain | 1993 |
A single case study using high-dose hydromorphone to control severe pain and serial psychometric testing to assess effects.
Topics: Humans; Hydromorphone; Language Tests; Male; Memory; Middle Aged; Pain; Prostatic Neoplasms | 1993 |
Opioid hyperexcitability: the application of alternate opioid therapy.
Topics: Adult; Aged; Drug Tolerance; Female; Humans; Hydromorphone; Male; Morphine; Myoclonus; Narcotics; Neoplasms; Pain | 1993 |
Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Bone Marrow Transplantation; Child; Child, Preschool; Female; Humans; Hydromorphone; Male; Morphine; Pain; Retrospective Studies; Treatment Outcome | 1995 |
Pain palliation with strontium-89 in children with metastatic disease.
Topics: Analgesics, Opioid; Bone Neoplasms; Carcinoma, Squamous Cell; Child; Cranial Irradiation; Fatal Outcome; Female; Humans; Hydromorphone; Injections, Intravenous; Lung Neoplasms; Male; Neoplasm Staging; Neuroblastoma; Osteoblasts; Pain; Palliative Care; Patient Discharge; Remission Induction; Spinal Cord; Strontium Radioisotopes | 1996 |
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydromorphone; Injections, Subcutaneous; Male; Methadone; Middle Aged; Morphine; Neoplasms; Pain; Retrospective Studies | 1996 |
Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
Topics: Analgesics; Animals; Azocines; Behavior, Animal; Benzeneacetamides; Female; Fentanyl; Hot Temperature; Hydromorphone; Macaca mulatta; Male; Morphine; Narcotic Antagonists; Pain; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1996 |
Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators.
Topics: Carcinoma, Renal Cell; Drug Administration Schedule; Humans; Hydromorphone; Kidney Neoplasms; Male; Methadone; Middle Aged; Narcotics; Pain; Palliative Care; Prognosis; Spinal Neoplasms | 1996 |
Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
Topics: Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Humans; Hydromorphone; Injections, Intravenous; Male; Methadone; Morphine; Pain; Palliative Care; Peritoneal Neoplasms; Retreatment; Stomach Neoplasms | 1997 |
Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion.
Topics: Analgesics, Opioid; Antiemetics; Breast Neoplasms; Drug Incompatibility; Female; Humans; Hydromorphone; Injections, Subcutaneous; Middle Aged; Nausea; Pain; Prochlorperazine; Solutions | 1997 |
Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study.
Topics: Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Palliative Care; Retrospective Studies | 1997 |
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Linear Models; Male; Methadone; Middle Aged; Neoplasms; Pain; Receptors, Opioid; Retrospective Studies | 1998 |
Analgesics in the management of chronic pain. Part four: Step 3 oral analgesic drug therapy.
Topics: Administration, Oral; Analgesics, Opioid; Chronic Disease; Dextromoramide; Drug Administration Schedule; Humans; Hydromorphone; Morphine; Pain | 1998 |
The relationship between the visual analog pain intensity and pain relief scale changes during analgesic drug studies in chronic pain patients.
Topics: Adult; Aged; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Pain; Pain Measurement; Regression Analysis | 1999 |
Opioid conversion guidelines for managing adult cancer pain.
Topics: Administration, Oral; Analgesics, Opioid; Chronic Disease; Female; Humans; Hydromorphone; Infusions, Intravenous; Mathematics; Middle Aged; Morphine; Neoplasms; Pain; Pain Measurement; Salvage Therapy; Therapeutic Equivalency; Titrimetry | 1999 |
Trends in medical use and abuse of opioid analgesics.
Topics: Analgesics, Opioid; Drug Utilization; Fentanyl; Humans; Hydromorphone; Meperidine; Morphine; Opioid-Related Disorders; Oxycodone; Pain; Retrospective Studies; Risk Assessment; Social Change; United States | 2000 |
Hydromorphone.
Topics: Analgesics, Opioid; Chronic Disease; Humans; Hydromorphone; Meperidine; Morphine; Neoplasms; Pain | 2001 |
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Topics: Administration, Oral; Analgesics, Opioid; Chemistry, Pharmaceutical; Drug Administration Schedule; Fentanyl; Humans; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Injections, Subcutaneous; Methadone; Morphine; Neoplasms; Oxycodone; Pain; Palliative Care | 2001 |
Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system.
Topics: Analgesics, Opioid; Anesthesia, Spinal; Anesthetics, Local; Bupivacaine; Chronic Disease; Drug Delivery Systems; Drug Stability; Drug Therapy, Combination; Humans; Hydromorphone; Morphine; Pain; Pain Measurement; Palliative Care; Retrospective Studies; Safety | 2001 |
[New Level III opioids of the World Health Organization].
Topics: Administration, Oral; Analgesics, Opioid; Clinical Trials as Topic; Delayed-Action Preparations; Fentanyl; Humans; Hydromorphone; Morphine; Neoplasms; Pain; World Health Organization | 2002 |
[Opioid rotation in pain therapy. Case report].
Topics: Administration, Cutaneous; Chronic Disease; Fentanyl; Humans; Hydromorphone; Injections, Subcutaneous; Male; Middle Aged; Morphine; Neoplasms; Pain | 2002 |
Assessment of biodegradable controlled release rod systems for pain relief applications.
Topics: Analgesics, Opioid; Biocompatible Materials; Biodegradation, Environmental; Codeine; Drug Delivery Systems; Hydromorphone; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Morphine; Pain; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Time Factors | 2002 |
Survey of pain management therapy provided for children with sickle cell disease.
Topics: Acetaminophen; Analgesics; Anemia, Sickle Cell; Child; Child, Preschool; Codeine; Drug Administration Schedule; Drug Combinations; Humans; Hydromorphone; Infant; Length of Stay; Meperidine; Morphine; Nalbuphine; Pain; Pain Management; Seizures | 1992 |
Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids.
Topics: Acetaminophen; Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Hydromorphone; Male; Meperidine; Middle Aged; Morphine; Morphine Derivatives; Neoplasms; Nicotinic Acids; Pain | 1992 |
Quaternary naloxone blocks morphine analgesia in spinal but not intact rats.
Topics: Animals; Denervation; Female; Hydromorphone; Morphine; Oxymorphone; Pain; Permeability; Rats; Rats, Inbred Strains; Spinal Cord | 1990 |
The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions.
Topics: Dose-Response Relationship, Drug; Female; Humans; Hydromorphone; Male; Models, Neurological; Narcotics; Nervous System Diseases; Pain; Pregnancy | 1990 |
Compatibility of hydromorphone hydrochloride and tetracaine hydrochloride.
Topics: Drug Incompatibility; Drug Interactions; Humans; Hydromorphone; Pain; Tetracaine; Time Factors | 1991 |
Continuous subcutaneous infusions. New use for an old route.
Topics: Aged; Female; Humans; Hydromorphone; Infusions, Parenteral; Ovarian Neoplasms; Pain | 1991 |
Antagonism of stress-induced analgesia by quaternary naloxone.
Topics: Analgesia; Animals; Drug Interactions; Electroshock; Hydromorphone; Male; Morphine; Oxymorphone; Pain; Rats; Rats, Inbred Strains; Reaction Time; Stress, Physiological | 1986 |
Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient.
Topics: Adult; Analgesics, Opioid; Combined Modality Therapy; Drug Tolerance; Female; Humans; Hydromorphone; Methadone; Morphine; Neoplasms; Pain | 1986 |
Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer.
Topics: Ambulatory Care; Female; Humans; Hydromorphone; Infusion Pumps; Male; Middle Aged; Morphine; Narcotics; Neoplasms; Pain | 1987 |
[Pain treatment during pregnancy and opiate addiction in both mother and child].
Topics: Adult; Analgesics, Opioid; Female; Humans; Hydromorphone; Infant, Newborn; Neonatal Abstinence Syndrome; Pain; Pancreatitis; Pregnancy; Pregnancy Complications, Infectious; Substance-Related Disorders | 1988 |
Combined neurogenic and nociceptive pain in a patient with Pancoast tumor managed by epidural hydromorphone and oral carbamazepine.
Topics: Administration, Oral; Carbamazepine; Humans; Hydromorphone; Injections, Spinal; Male; Middle Aged; Pain; Pancoast Syndrome | 1989 |
Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain.
Topics: Adult; Aged; Erythema; Female; Humans; Hydromorphone; Infusions, Parenteral; Male; Middle Aged; Necrosis; Neoplasms; Pain; Skin | 1989 |
Failure of epidural opioid to control cancer pain in a patient previously treated with massive doses of intravenous opioid.
Topics: Adenocarcinoma; Bupivacaine; Cecal Neoplasms; Clonidine; Female; Humans; Hydromorphone; Infusions, Intravenous; Injections, Epidural; Lidocaine; Middle Aged; Pain; Substance Withdrawal Syndrome | 1989 |
Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine.
Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Guinea Pigs; Hydromorphone; Male; Mice; Muscle, Smooth; Naltrexone; Narcotic Antagonists; Oxymorphone; Pain; Structure-Activity Relationship | 1989 |
A spirohydantoin derivative of oxymorphone: an agonist with delayed antagonist activity.
Topics: Analgesia; Animals; Anticonvulsants; Behavior, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation, Preclinical; Hydantoins; Hydromorphone; Male; Mice; Morphine; Oxymorphone; Pain; Sensory Thresholds; Time Factors | 1989 |
Home intravenous opioid therapy in a toddler with advanced cancer.
Topics: Brain Neoplasms; Child, Preschool; Cranial Fossa, Posterior; Home Care Services; Humans; Hydromorphone; Injections, Intravenous; Male; Medulloblastoma; Pain | 1989 |
[Analgesia in myocardial infarct].
Topics: Analgesics; Diazepam; Heart; Hemodynamics; Heroin; Humans; Hydromorphone; Meperidine; Methadone; Morphine; Myocardial Infarction; Nitrogen Oxides; Pain; Pentazocine; Respiration | 1974 |
Synthesis and pharmacology of 6-methylenedihydrodesoxymorphine.
Topics: Adult; Analgesia; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Chemistry, Organic; Cortisone; Diuresis; Drug Tolerance; Female; Gastrointestinal Motility; Humans; Hydromorphone; Male; Middle Aged; Morphine; Nalorphine; Organic Chemistry Phenomena; Pain; Rats; Respiration | 1966 |
Dental evaluation of hydromorphone (Dilaudid) for oral and maxillo-facial surgery.
Topics: Hydromorphone; Meperidine; Pain; Postoperative Care; Surgery, Oral | 1969 |